SignatureFD’s Zomedica Corp. ZOM Stock Holding History

SignatureFD’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-9,000	Closed	-$2K	–	2838
2020 Q2	$2K	Buy	+9,000	New	+$1.72K	﹤0.01%	2243

Other funds holding ZOM

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Winton Group London, United Kingdom $2.85B AUM 30.73% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

SignatureFD's ZOM Position: Q3 2020 in Review

SignatureFD sold out of Zomedica Corp. (ZOM) in Q3 2020, closing a stake of 9,000 shares — an estimated $2K sold.

SignatureFD first reported a position in ZOM in Q2 2020 and held it in 1 quarter. The position peaked at $2K in Q2 2020. 32 funds tracked by Wall St. Rank hold ZOM as of Q3 2020.

SignatureFD reported no remaining Zomedica Corp. position as of Q3 2020 after selling out during the quarter.
SignatureFD sold 9,000 Zomedica Corp. shares in Q3 2020, an estimated $2K.
SignatureFD first reported a position in Zomedica Corp. in Q2 2020 and held it in 1 quarter.
SignatureFD's Zomedica Corp. position peaked at $2K in Q2 2020.
32 funds tracked by Wall St. Rank held Zomedica Corp. as of Q3 2020.

Based on SignatureFD's 13F filing for Q3 2020, filed 3 Nov 2020.